NCT03302533

Brief Summary

Total elbow arthroplasty (TEA) results in immediate pain release with good functional results after distal humerus fractures. But still open reduction and internal fixation is recommended as treatment of choise due to a lifelong loading limitiation, unknown implant survival and problematic revision surgery after TEA. The purpose of this study was to compare functional results and complication rates after primary total elbow arthroplasty (TEA) and TEA after failed reconstruction or non-operative treatment (secondary TEA) in the treatment of distal humerus fractures. We hypothesised that clinical and functional results are better for primary TEA with less complications.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 21, 2013

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 30, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 5, 2017

Completed
Last Updated

October 5, 2017

Status Verified

October 1, 2017

Enrollment Period

3.2 years

First QC Date

September 30, 2017

Last Update Submit

October 4, 2017

Conditions

Keywords

distal humerus fracturetotal elbow arthroplastyelbow prosthesisdelayed arthroplastyrevision surgery

Outcome Measures

Primary Outcomes (2)

  • Range of motion

    Measurement of the range of motion for extension/flexion

    minimum follow-up: 6 months

  • Mayo Elbow Performance Score

    Objective score evaluation the function of the elbow

    minimum follow-up: 6 months

Secondary Outcomes (1)

  • Complication

    minimum follow-up: 6 months

Other Outcomes (1)

  • DASH score

    minimum follow-up: 6 months

Study Arms (2)

Primary arthroplasty

All patients who received TEA for an acute trauma with fracture of the distal humerus.

Procedure: Total elbow arthroplasty

Secondary arthroplasty

All patients who received TEA due to a failed reconstruction or non-operative treatment after a distal humerus fracture.

Procedure: Total elbow arthroplasty

Interventions

Implantation of a total elbow arthroplasty after distal humerus fracture

Primary arthroplastySecondary arthroplasty

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Out of 35 patients, who fit the inclusion criteria, six had died from unrelated causes. 23 patients participated in the study, since six patients were lost to follow-up. Nine of the 23 patients (mean age: 70 years; 8 women) had implantation of a primary TEA. The remaining 14 patients (mean age: 63 years; 11 women) received secondary implantation of a TEA. The secondary TEA was implanted after an implant failure in four patients, twice because of a non-union (one after reconstruction and one after non-operative therapy), and in three patients because of a non-union with an additional partial necrosis of the distal humerus. Two patients received secondary TEA because of a posttraumatic arthritis after internal fixation and three times because of a posttraumatic arthritis after non-operative treatment. The mean follow-up was 28 months (range: 6 - 73) with a mean age of 66 years (range: 41 - 85).

You may qualify if:

  • Total elbow arthroplasty for an acute trauma with fracture due to an acute trauma
  • Total elbow arthroplasty due to failed reconstruction after distal humerus fracture
  • Total elbow arthroplasty after non-operatic treatment after distal humerus fracture

You may not qualify if:

  • previous injury at the fractured elbow
  • neuro-muscular disease
  • cortisone or other immune suppressive therapy
  • open fracture grade II or higher according to Tscherne and Ostern

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Elbow FracturesHumeral Fractures, Distal

Interventions

Arthroplasty, Replacement, Elbow

Condition Hierarchy (Ancestors)

Elbow InjuriesArm InjuriesWounds and InjuriesFractures, BoneHumeral Fractures

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Physician

Study Record Dates

First Submitted

September 30, 2017

First Posted

October 5, 2017

Study Start

January 21, 2013

Primary Completion

March 31, 2016

Study Completion

March 31, 2017

Last Updated

October 5, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share